Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lucia Fiorillo"'
Autor:
Asad Ali, Katia Grillone, Serena Ascrizzi, Giulio Caridà, Lucia Fiorillo, Domenico Ciliberto, Nicoletta Staropoli, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Di Martino
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 2, Pp 102221- (2024)
Colorectal cancer (CRC) is one of the most common malignancies and a relevant cause of cancer-related deaths worldwide. Dysregulation of microRNA (miRNA) expression has been associated with the development and progression of various cancers, includin
Externí odkaz:
https://doaj.org/article/3da076c66b4d4799a8feb9a8d50480d2
Autor:
Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, Lucia Fiorillo, Nicoletta Staropoli, Domenico Ciliberto, Alessia Cordua, Francesca Scionti, Bernardo Bertucci, Angela Salvino, Mariangela Lopreiato, Fredrik Thunarf, Onofrio Cuomo, Maria Cristina Zito, Maria Rosanna De Fina, Amelia Brescia, Simona Gualtieri, Caterina Riillo, Francesco Manti, Daniele Caracciolo, Vito Barbieri, Eugenio Donato Di Paola, Adele Emanuela Di Francesco, Pierosandro Tagliaferri
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background We developed a 13-mer locked nucleic acid (LNA) inhibitor of miR-221 (LNA-i-miR-221) with a full phosphorothioate (PS)-modified backbone. This agent downregulated miR-221, demonstrated anti-tumor activity against human xenografts
Externí odkaz:
https://doaj.org/article/4d9a753abc2e49c2bbde30064f04d177
Autor:
Maria d’Apolito, Rocco Spagnuolo, Maria Anna Siciliano, Vito Barbieri, Cristina Cosco, Lucia Fiorillo, Onofrio Cuomo, Valeria Zuccalà, Pierpaolo Correale, Licia Pensabene, Marco Rossi, Patrizia Doldo, Pierfrancesco Tassone, Pierosandro Tagliaferri
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Immune checkpoint inhibitors (ICIs) represent an important advance in the adjuvant treatment of patients with high-risk melanoma. Although the safety profile of anti-programmed cell death protein-1 (PD-1) is fairly acceptable, different immune-relate
Externí odkaz:
https://doaj.org/article/3140e4e3d7bb48529700ea1b69df5dc3
Autor:
Michele Caraglia, Lucia Fiorillo, Stefania Lama, Domenico Ciliberto, Anna Grimaldi, Cirino Botta, Pierosandro Tagliaferri, Angela Salvino, Pierfrancesco Tassone, Nicoletta Staropoli
Publikováno v:
Cancer Biology & Therapy. 15:707-720
Ovarian cancer is the leading cause of death among gynecological tumors. Carboplatin/paclitaxel represents the cornerstone of front-line treatment. Instead, there is no consensus for management of recurrent/progressive disease, in which pegylated lip
Autor:
Caterina Viscomi, Pierosandro Tagliaferri, Nicoletta Staropoli, Pierfrancesco Tassone, Cirino Botta, Simona Gualtieri, Domenico Ciliberto, Antonina Maria De Angelis, Lucia Fiorillo, Angela Salvino
Publikováno v:
Journal of Cancer Therapy. :1005-1017
Epithelial ovarian cancer (EOC) is the sixth most common malignancy in women. Ovarian tumors consist of several clinical and pathological entities that share an anatomic site. The gold standard treatment, both in front-line and in adjuvant setting, i
Autor:
Eleonora Iuliano, Domenico Ciliberto, Lucia Fiorillo, Teresa Del Giudice, Pierosandro Tagliaferri
Publikováno v:
Molecular Targets and Strategies in Cancer Prevention ISBN: 9783319312521
Recent findings have disclosed the complexity of large bowel microbiota which includes bacteria, viruses and unicellular eukaryotes. Bacteria represents 90 % of human gut microbiota.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2779b3399c0cd262f04acffcd5a0573d
https://doi.org/10.1007/978-3-319-31254-5_2
https://doi.org/10.1007/978-3-319-31254-5_2
Autor:
F. Caglioti, Lucia Fiorillo, Francesco Mendicino, Pierosandro Tagliaferri, Cirino Botta, Domenico Ciliberto, Pierfrancesco Tassone, Nicoletta Staropoli, Silvia Chiellino, Simona Gualtieri, Antonina Maria De Angelis, Michele Caraglia
It is still uncertain if targeted therapy-based regimens in advanced gastric cancer actually produce survival benefit. To shed light on this important question, we performed a systematic review and meta-analyses on each relevant targeted-pathway. By
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668fa7309d7aaad4ea75fa8111f7d541
https://europepmc.org/articles/PMC4623405/
https://europepmc.org/articles/PMC4623405/
Autor:
Pierfrancesco Tassone, Daniele Caracciolo, Pierosandro Tagliaferri, Lucia Fiorillo, Maria Cucè, Cirino Botta
Publikováno v:
Current Cancer Drug Targets. 17:1-1
Multiple myeloma (MM) is an incurable plasma cell neoplasm accounting for about 10% of all hematologic malignancies. Recently, emerging evidence is disclosing the complexity of bone marrow interactions between MM cells and infiltrating immune cells,
Autor:
Amalia Luce, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicoletta Staropoli, Lucia Fiorillo, Simona Gualtieri, Michele Caraglia, Anna Grimaldi, Domenico Ciliberto, Iole Cucinotto, Mariamena Arbitrio
Publikováno v:
Journal of Drug Delivery (Online) Volume 2013 (2013): 1–10.
info:cnr-pdr/source/autori:Iole Cucinotto,1 Lucia Fiorillo,1 Simona Gualtieri,1 Mariamena Arbitrio,2 Domenico Ciliberto,1 Nicoletta Staropoli,1 Anna Grimaldi,3 Amalia Luce,3 Pierfrancesco Tassone,1 Michele Caraglia,3 and Pierosandro Tagliaferri1/titolo:Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?/doi:/rivista:Journal of Drug Delivery (Online)/anno:2013/pagina_da:1/pagina_a:10/intervallo_pagine:1–10/volume:Volume 2013
Journal of Drug Delivery, Vol 2013 (2013)
Journal of Drug Delivery
info:cnr-pdr/source/autori:Iole Cucinotto,1 Lucia Fiorillo,1 Simona Gualtieri,1 Mariamena Arbitrio,2 Domenico Ciliberto,1 Nicoletta Staropoli,1 Anna Grimaldi,3 Amalia Luce,3 Pierfrancesco Tassone,1 Michele Caraglia,3 and Pierosandro Tagliaferri1/titolo:Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?/doi:/rivista:Journal of Drug Delivery (Online)/anno:2013/pagina_da:1/pagina_a:10/intervallo_pagine:1–10/volume:Volume 2013
Journal of Drug Delivery, Vol 2013 (2013)
Journal of Drug Delivery
Nanoparticle albumin bound paclitaxel (nab-paclitaxel) represents the first nanotechnology-based drug in cancer treatment. We discuss the development of this innovative compound and report the recent changing-practice results in breast and pancreatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be530cecb04e22bed67c2750e5f69847
http://hdl.handle.net/11591/321178
http://hdl.handle.net/11591/321178
Autor:
Pierosandro Tagliaferri, Angela Salvino, Domenico Ciliberto, Nicoletta Staropoli, Pierfrancesco Tassone, Lucia Fiorillo, Simona Gualtieri, Cirino Botta
Publikováno v:
Journal of Ovarian Research
Background Ovarian cancer (OC) is the sixth most common cancer in women. Currently, carboplatin/paclitaxel ± bevacizumab is the cornerstone of front-line treatment. Conversely, the therapeutic options for recurrent or progressive disease are not wel